Simplicity Solutions’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Simplicity Solutions’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,200	Closed	-$42.8K	–	1285
2023 Q1	$42.8K	Buy	+10,200	New	+$52.9K	﹤0.01%	1100

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Simplicity Solutions's CTIC Position: Q2 2023 in Review

Simplicity Solutions sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 10,200 shares — an estimated $42.8K sold.

Simplicity Solutions first reported a position in CTIC in Q1 2023 and held it in 1 quarter. The position peaked at $42.8K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Simplicity Solutions reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Simplicity Solutions sold 10,200 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $42.8K.
Simplicity Solutions first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2023 and held it in 1 quarter.
Simplicity Solutions's CTI BioPharma Corp. (DE) Common Stock position peaked at $42.8K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Simplicity Solutions's 13F filing for Q2 2023, filed 26 Jul 2023.